Immunopharmacology and inflammation
Antiviral activity of aloe-emodin against influenza A virus via galectin-3 up-regulation
Abstract
Novel
influenza A H7N9 virus, which emerged in 2013, and highly pathogenic
H5N1 virus, identified since 2003, pose challenges to public health and
necessitate quest for new anti-influenza compounds. Anthraquinone
derivatives like aloe-emodin, emodin and chrysophanol, reportedly
exhibit antiviral activity. This study probes their inhibitory mechanism
and effect against influenza A virus. Of three anthraquinone
derivatives, aloe-emodin, with a lower cytotoxicity showed
concentration-dependently reducing virus-induced cytopathic effect and
inhibiting replication of influenza A in MDCK cells. 50% inhibitory
concentration value of aloe-emodin on virus yield was less than
0.05 μg/ml. Proteomics and Western blot of MDCK cells indicated
aloe-emodin up-regulating galectin-3, and thioredoxin as well as
down-regulating nucleoside diphosphate kinase A. Western blot and
quantitative PCR confirmed aloe-emodin up-regulating galectin-3
expression; recombinant galectin-3 augmented expression of antiviral
genes IFN-β, IFN-γ, PKR and 2׳,5׳–OAS in infected cells, agreeing with
expression pattern of those treated with aloe-emodin. Galectin-3 also
inhibited influenza A virus replication. Proteomic analysis of treated
cells indicated galectin-3 up-regulation as one anti-influenza A virus
action by aloe-emodin. Since galectin-3 exhibited cytokine-like
regulatory actions via JAK/STAT pathways, aloe-emodin also restored
NS1-inhibited STAT1-mediated antiviral responses in transfected cells:
e.g., STAT1 phosphorylation of interferon (IFN) stimulation response
element (ISRE)-driven promoter, RNA-dependent protein kinase (PKR) and
2׳,5׳-oligoadenylate synthetase (2׳,5׳–OAS) expression. Treatment with
aloe-emodin could control influenza infection in humans.
Keywords
- Influenza A virus;
- Anthraquinone;
- Aloe-emodin;
- Galectin-3
Copyright © 2014 Elsevier B.V. All rights reserved.